Skip to main content

Retail Clinics

  • Bayer Advanced Aspirin officially launches

    MORRISTOWN, N.J. — Bayer on Tuesday introduced its new Bayer Advanced Aspirin, billed as relieving pain “twice as fast” as the previous Extra Strength Bayer Aspirin.

    Using a patent-pending Pro-Release technology, the particles in the new formulation are one-tenth the size of Extra Strength Bayer Aspirin and dissolve six times faster.

  • Study finds possible link between ADT, diabetes

    BOSTON — Men with prostate cancer are at a higher risk of developing diabetes or diabetes risk factors if they receive a therapy designed to block the production of testosterone, a new study has suggested.

  • MinuteClinic, OhioHealth enter strategic clinical affiliation

    WOONSOCKET, R.I., and COLUMBUS, Ohio — MinuteClinic has entered a clinical affiliation with OhioHealth, a not-for-profit, charitable healthcare organization based in Columbus. MinuteClinic has seven walk-in medical clinics inside select CVS/pharmacy stores throughout the region.

  • Health 2.0, Walgreens announce health guide challenge

    SAN FRANCISCO — Health 2.0 and Walgreens on Thursday announced the launch of the Walgreens 2011 Challenge: A New Approach to Patient Information Navigation, which invites teams of developers to create an application that presents aggregated U.S. Department of Health and Human Services data on specific health topics.

    The challenge is being sponsored by Walgreens, as part of the Health 2.0 Developer Challenge, as a way to supply both Walgreens healthcare staff and patients with a tool for searching and learning about health-related topics, the companies stated.

  • H1N1 flu variant may be resistant to certain treatments

    NEW YORK — A new strain of swine flu has emerged that appears somewhat resistant to flu drugs, according to published reports.

    Reuters reported that scientists in Australia and Singapore had found a variant of the H1N1 flu that showed some resistance to Roche’s Tamiflu (oseltamivir phosphate) and GlaxoSmithKline’s Relenza (zanamivir), though drug maker BioCryst currently is developing a drug called peramivir, to which the strain was not resistant.

  • MinuteClinic to collaborate with Cleveland Clinic Florida

    WOONSOCKET, R.I. — MinuteClinic and Cleveland Clinic Florida, a multispecialty academic medical center that is part of the Cleveland Clinic health system, have entered into a clinical affiliation to enhance the healthcare services they provide and offer patients greater access to care.

  • FDA recommends limiting use of simvastatin in 80-mg strength

    SILVER SPRING, Md. — The Food and Drug Administration is seeking to limit the use of high doses of a drug for high cholesterol due to the risk of a muscle injury known as myopathy.

  • FDA approves labeling change for Eli Lilly insulin product

    INDIANAPOLIS — Patients with Type 1 diabetes using an insulin product made by Eli Lilly can store it in their pumps for longer periods of time, while children using it have additional options, thanks to a labeling change approved Wednesday by the Food and Drug Administration.

X
This ad will auto-close in 10 seconds